Skip to content
MIZAANIntelligence
Health
Photo: MART PRODUCTION / Pexels
Health

FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease

FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pediatric patients weighing at least 15 kg (approximately 33 pounds).

141 source2d ago

Edited by Shakil Javed · AI-assisted summary from 1 cited source ·

Illustrative photos

Lab technician using a syringe to handle a blood sample. Medical analysis concept.
Photo: kaboompics / Pexels · illustrative, not of the event
A medical professional using pipette in a lab setting, emphasizing precision and care.
Photo: Diego Romero / Pexels · illustrative, not of the event

Sources · 1 report

  1. 01
    U.S. FDA — Press Releases· 2d ago

    FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease

    FDA today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pediatric patients weighing at least 15 kg (approximately 33 pounds).

    Read at source

Headlines and short deks only, each linked to its source. We never republish article text.

Report an error

Start your day with Mizaan Morning

The five ranked stories that matter and source-stamped market figures — one email each trading morning.

We’ll email a confirmation link before sending anything. Unsubscribe anytime.